Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/E ratio is N/A as of 2026-10-06T22:20:39.944Z.
Calculation as of: 2026-10-06T22:20:39.944Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e4092e053989caac2e99517ddb979985c78622fc494c6088febce458b2dbbcab
PE RATIO
N/A
PE RATIO AVG TTM
N/A
PE RATIO AVG 3Y
N/A
PE RATIO AVG 5Y
N/A
PE RATIO AVG 10Y
N/A
PE RATIO AVG 15Y
N/A
PE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$265.78M
PE Ratio
N/A
TTM Avg
15.73
3Y Avg
15.73
5Y Avg
15.86
Market Cap
$262.92M
PE Ratio
N/A
TTM Avg
175.46
3Y Avg
175.46
5Y Avg
175.46
Market Cap
$271.81M
PE Ratio
N/A
TTM Avg
39.79
3Y Avg
40.81
5Y Avg
32.75
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SAB Biotherapeutics, Inc. (SABS) | $266.59M | N/A | N/A | N/A | N/A |
| Fate Therapeutics, Inc. (FATE)vs › | $266.92M | N/A | N/A | N/A | N/A |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $265.78M | N/A | 15.73 | 15.73 | 15.86 |
| Scribe Therapeutics Inc. (SCTX)vs › | $264.25M | N/A | N/A | N/A | N/A |
| TriSalus Life Sciences, Inc. (TLSI)vs › | $262.92M | N/A | 175.46 | 175.46 | 175.46 |
| Rocket Pharmaceuticals, Inc. (RCKT)vs › | $270.80M | N/A | N/A | N/A | N/A |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $261.43M | N/A | N/A | N/A | N/A |
| Vanda Pharmaceuticals Inc. (VNDA)vs › | $271.81M | N/A | 39.79 | 40.81 | 32.75 |
| X4 Pharmaceuticals, Inc. (XFOR)vs › | $261.27M | N/A | 4.20 | 4.20 | 4.20 |
| OraSure Technologies, Inc. (OSUR)vs › | $259.56M | N/A | 16.07 | 13.93 | 35.67 |
Trailing P/E
N/A
Forward P/E
N/A
Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$2.93
Forward EPS (Est.)
$-1.21
Forward P/E
N/A
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PE RATIO |
|---|---|
| 2022-03-29 | 2.80 |
| 2022-03-28 | 2.61 |
| 2022-03-25 | 2.43 |
| 2022-03-24 | 2.54 |
| 2022-03-23 | 2.75 |
| 2022-03-22 | 2.60 |
| 2022-03-21 | 2.34 |
| 2022-03-18 | 2.49 |
| 2022-03-17 | 2.29 |
| 2022-03-16 | 2.22 |
| 2022-03-15 | 2.27 |
| 2022-03-14 | 2.23 |
| 2022-03-11 | 2.44 |
| 2022-03-10 | 2.66 |
| 2022-03-09 | 2.84 |
| 2022-03-08 | 2.85 |
| 2022-03-07 | 2.87 |
| 2022-03-04 | 3.14 |
| 2022-03-03 | 3.36 |
| 2022-03-02 | 3.43 |
| 2022-03-01 | 5.71 |
| 2022-02-28 | 6.17 |
| 2022-02-25 | 6.19 |
| 2022-02-24 | 6.33 |
| 2022-02-23 | 6.21 |
| 2022-02-22 | 6.48 |
| 2022-02-18 | 6.21 |
| 2022-02-17 | 6.48 |
| 2022-02-16 | 6.71 |
| 2022-02-15 | 6.71 |
| 2022-02-14 | 6.37 |
| 2022-02-11 | 6.99 |
| 2022-02-10 | 6.91 |
| 2022-02-09 | 6.60 |
| 2022-02-08 | 6.35 |
| 2022-02-07 | 6.68 |
| 2022-02-04 | 7.07 |
| 2022-02-03 | 6.51 |
| 2022-02-02 | 6.81 |
| 2022-02-01 | 7.27 |
| 2022-01-31 | 7.23 |
| 2022-01-28 | 6.45 |
| 2022-01-27 | 5.95 |
| 2022-01-26 | 6.53 |
| 2022-01-25 | 7.42 |
| 2022-01-24 | 7.58 |
| 2022-01-21 | 6.82 |
| 2022-01-20 | 7.24 |
| 2022-01-19 | 7.14 |
| 2022-01-18 | 7.31 |
| 2022-01-14 | 8.40 |
| 2022-01-13 | 8.86 |
| 2022-01-12 | 9.41 |
| 2022-01-11 | 9.55 |
| 2022-01-10 | 9.52 |
| 2022-01-07 | 9.17 |
| 2022-01-06 | 9.55 |
| 2022-01-05 | 9.70 |
| 2022-01-04 | 9.99 |
| 2022-01-03 | 10.58 |
| 2021-12-31 | 9.72 |
| 2021-12-30 | 9.91 |
| 2021-12-29 | 10.82 |
| 2021-12-28 | 11.03 |
| 2021-12-27 | 11.24 |
| 2021-12-23 | 10.89 |
| 2021-12-22 | 10.77 |
| 2021-12-21 | 10.63 |
| 2021-12-20 | 10.69 |
| 2021-12-17 | 10.93 |
| 2021-12-16 | 11.36 |
| 2021-12-15 | 12.13 |
| 2021-12-14 | 11.14 |
| 2021-12-13 | 11.60 |
| 2021-12-10 | 11.34 |
| 2021-12-09 | 11.28 |
| 2021-12-08 | 11.30 |
| 2021-12-07 | 11.13 |
| 2021-12-06 | 10.91 |
| 2021-12-03 | 12.30 |
| 2021-12-02 | 12.84 |
| 2021-12-01 | 13.99 |
| 2021-11-30 | 13.55 |
| 2021-11-29 | 12.72 |
| 2021-11-26 | 13.07 |
| 2021-11-24 | 11.08 |
| 2021-11-23 | 10.70 |
